Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Invalid results on vidas toxo igg avidity (ref. 30222) may occurs when it is necessary to bring the sample titer to theoretical 15 ui/ml. this issue can occur when applying an inappropriate dilution factor when testing the sample on vidas toxo igg avidity which leads to invalid results. this issue cannot lead to false results on vidas toxo igg avidity.